Intrinsic functional and architectonic heterogeneity of tumor-targeted protein nanoparticles

Author

Pesarrodona Roches, Mireia

Crosas, Eva

Cubarsi, Rafael

Sánchez Chardi, Alejandro

Saccardo, Paolo

Unzueta Elorza, Ugutz

Rueda, Fabian

Sánchez García, Laura

Serna, Naroa

Mangues, Ramon

Ferrer-Miralles, Neus

Vázquez Gómez, Esther

Villaverde Corrales, Antonio

Universitat Autònoma de Barcelona

Publication date

2017

Abstract

Altres ajuts: CIBER de Bioingeniería, Biomateriales y Nanomedicina (project NANOPROTHER) (to AV), Marató de TV3 foundation (TV32013-132031) (TV32013-133930). Protein production has been partially performed by the ICTS "NANBIOSIS", more specifically by the Protein Production Platform of CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN)/IBB, at the UAB SepBioES scientific-technical service (http://www.nanbiosis.es/unit/u1-protein-production-platform-ppp/) and DLS measurements have been done at the Biomaterial Processing and Nanostructuring Unit of NANBIOSIS. We are also indebted to Fran Cortés from the Cell Culture and Cytometry Units of the Servei de CultiusCel·lulars, Producciód'AnticossosiCitometria (SCAC), and to the Servei de Microscòpia, both at the UAB. Strain KPM335 was kindly provided by Research Corporation Technologies, Tucson, AZ. AV received an ICREA ACADEMIA award.


Self-assembling proteins are gaining attention as building blocks for application-tailored nanoscale materials. This is mostly due to the biocompatibility, biodegradability, and functional versatility of peptide chains. Such a potential for adaptability is particularly high in the case of recombinant proteins, which are produced in living cells and are suitable for genetic engineering. However, how the cell factory itself and the particular protein folding machinery influence the architecture and function of the final material is still poorly explored. In this study we have used diverse analytical approaches, including small-angle X-ray scattering (SAXS) and field emission scanning electron microscopy (FESEM) to determine the fine architecture and geometry of recombinant, tumor-targeted protein nanoparticles of interest as drug carriers, constructed on a GFP-based modular scheme. A set of related oligomers were produced in alternative Escherichia coli strains with variant protein folding networks. This resulted in highly regular populations of morphometric types, ranging from 2.4 to 28 nm and from spherical- to rod-shaped materials. These differential geometric species, whose relative proportions were determined by the features of the producing strain, were found associated with particular fluorescence emission, cell penetrability and receptor specificity profiles. Then, nanoparticles with optimal properties could be analytically identified and further isolated from producing cells for use. The cell's protein folding machinery greatly modulates the final geometry reached by the constructs, which in turn defines the key parameters and biological performance of the material.

Document Type

Article

Language

English

Subjects and keywords

Analytical approach; Biological performance; Field emission scanning electron microscopy; Fluorescence emission; Nano-scale materials; Optimal properties; Specificity profile; Targeted proteins; Cell Line, Tumor; Drug Carriers; Fluorescence; Green Fluorescent Proteins; HeLa Cells; Humans; Microscopy, Electron, Scanning; Nanoparticles; Neoplasms; Recombinant Proteins; Scattering, Small Angle; X-Ray Diffraction

Publisher

 

Related items

Ministerio de Economía y Competitividad BIO2013-41019-P

Instituto de Salud Carlos III PI15/00378

Instituto de Salud Carlos III PI15/00272

Agència de Gestió d'Ajuts Universitaris i de Recerca 2016/FI_B00034

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014/SGR-132

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014/PROD00055

Nanoscale ; Vol. 9, issue 19 (May 2017), p. 6427-6435

Rights

open access

Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.

https://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)